DEA Archived Press Releases

Press Releases before January 20, 2025
10 Results - Showing 1 to 10
PRESS RELEASE

Two MS-13 Leaders Convicted of Racketeering Conspiracy and Conspiring to Commit Multiple Murders

Washington, D.C. - Yesterday, a federal jury in Maryland convicted two El Salvadorian nationals for conspiring to participate in La Mara Salvatrucha, a transnational criminal enterprise, commonly known as MS-13. Junior Noe Alvarado-Requeno, aka Insolente, aka Trankilo, 25, and Miguel Angel Corea Diaz, aka Reaper, 39, were convicted of multiple...
PRESS RELEASE

Administrator Anne Milgram Remarks on the Overdose Epidemic

Thank you and good morning. Thank you to ONDCP and to all the federal partners with whom we have been working on this important issue. This is a critical moment in our country. DEA’s mission is to keep American communities safe and healthy and we are in the midst of...
PRESS RELEASE

DEA Finalizes Measures to Expand Medication-Assisted Treatment

WASHINGTON – The Drug Enforcement Administration today announced an important step to improve access to medications for opioid use disorder, especially in rural areas where those suffering with opioid use disorder may have limited treatment options. Under the final rule published today, DEA registrants who are authorized to dispense methadone...
PRESS RELEASE

DEA honors federal prosecutors for exemplary work in drug-related cases

SAN DIEGO – The Drug Enforcement Administration San Diego Field Division presented awards to several federal prosecutors for their exemplary service and dedication to DEA’s mission in San Diego and the surrounding counties. “It was an honor and a privilege to recognize these Assistant U.S. Attorneys along with U.S. Attorney...
PRESS RELEASE

DEA announces launch of Project Safeguard

WASHINGTON – Drug Enforcement Administration Acting Administrator Timothy J. Shea today announced that the DEA will direct resources to help reduce violent crime in communities throughout the country. Under this initiative, called Project Safeguard, DEA will identify and prioritize ongoing drug trafficking investigations with a nexus to violent crime. “D...
PRESS RELEASE

International law enforcement operation targeting opioid traffickers on the Darknet results in over 170 arrests worldwide and the seizure of weapons, drugs and over $6.5 million

WASHINGTON – Today, the Department of Justice, through the Joint Criminal Opioid and Darknet Enforcement team, joined Europol to announce the results of Operation DisrupTor, a coordinated international effort to disrupt opioid trafficking on the Darknet. The operation, which was conducted across the United States and Europe, demonstrates the continued...
PRESS RELEASE

DEA, DOD, DHS and U.S. Coast Guard announce offload of more than 33,000 pounds of seized drugs in Fort Lauderdale

FORT LAUDERDALE, Fla. – The Drug Enforcement Administration, Department of Defense, and Department of Homeland Security, and U.S. Coast Guard announced today a significant offload of drugs seized in international waters in the Eastern Pacific Ocean and Caribbean Sea. Agents with the DEA and the crew of the USCG Cutter...
PRESS RELEASE

DEA proposes process to expand marijuana research in the United States

WASHINGTON – Today, the Drug Enforcement Administration and the Department of Justice announced action to further expand opportunities for scientific and medical research on marijuana in the United States. The Notice of Proposed Rulemaking provides details on the proposed process and was filed for public inspection today, March 20. The...
PRESS RELEASE

Vice President attends $569 million cocaine offload in Coronado

CORONADO , Calif. – On July 11, 2019, Vice President Mike Pence, Office of National Drug Control Policy Director James W. Carroll, Drug Enforcement Administration Acting Administrator Uttam Dhillon, and Vice Admiral Linda Fagan, commander of Coast Guard Pacific Area, attended a United States Coast Guard drug offload at Naval...
PRESS RELEASE

FDA-approved drug Epidiolex placed in schedule V of Controlled Substance Act

WASHINGTON - The Department of Justice and Drug Enforcement Administration today announced that Epidiolex, the newly approved medication by the Food & Drug Administration, is being placed in schedule V of the Controlled Substances Act, the least restrictive schedule of the CSA. In June 2018, the FDA announced it approved...